Clinical Trial Update: Ingenol Mebutate 0.015% Gel in the Treatment of Actinic Keratoses (AK) on the Face and Scalp [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating Ingenol Mebutate 0.015% gel for actinic keratoses on the face and scalp has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis

Drugs mentioned

• Ingenol Mebutate Gel, 0.015% (ingenol mebutate)

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Actinic Keratosis | Phase 1 | Status: COMPLETED